From the CLP article by By Silvia Cermelli, PhD, and Prashant Wani, PhD:
Making a Breakthrough in Rapid Sepsis Diagnosis
Immunexpress’s SeptiCyte RAPID measures host response to differentiate sepsis from non-infectious systemic inflammation (i.e., SIRS). It is an FDA cleared test for this purpose and has a one-hour turnaround time requiring minimal technician hands-on time. SeptiCyte RAPID measures gene expression of two host immune response biomarkers, PLAC8 and PLA2G7, from peripheral blood injected into the fully automated sample-to-answer Biocartis Idylla system.
Source: Clinical Lab Products